Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents
- 31 October 2017
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 17 (1) , 51-54
Abstract
Introduction: To determine, via narrative, non-systematic review of pre-clinical and clinical studies, whether the effect of cannabis on hepatic biotransformation pathways would be predicted to result in clinically significant drug-drug interactions (DDIs) with commonly prescribed psychotropic agents. Areas covered: A non-systematic literature search was conducted using the following databases: PubMed, PsycInfo, and Scopus from inception to January 2017. The search term cannabis was cross-referenced with the terms drug interactions, cytochrome, cannabinoids, cannabidiol, and medical marijuana. Pharmacological, molecular, and physiologic studies evaluating the pharmacokinetics of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), both in vitro and in vivo, were included. Bibliographies were also manually searched for additional citations that were relevant to the overarching aim of this paper. Expert opinion: Δ9-Tetrahydrocannabinol and CBD are substrates and inhibitors of cytochrome P450 enzymatic pathways relevant to the biotransformation of commonly prescribed psychotropic agents. The high frequency and increasing use of cannabis invites the need for healthcare providers to familiarize themselves with potential DDIs in persons receiving select psychotropic agents, and additionally consuming medical marijuana and/or recreational marijuana.Keywords
This publication has 25 references indexed in Scilit:
- Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis usersThe American Journal of Drug and Alcohol Abuse, 2013
- Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for useInternational Journal of Drug Policy, 2013
- Drug Interactions between Common Illicit Drugs and Prescription TherapiesThe American Journal of Drug and Alcohol Abuse, 2012
- Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomesLife Sciences, 2011
- The pharmacology of cannabinoid receptors and their ligands: an overviewInternational Journal of Obesity, 2006
- Metabolism of Δ9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeysLife Sciences, 1995
- Cytochrome P450 Isozymes and Antiepileptic Drug InteractionsEpilepsia, 1995
- Blood Cannabinoids. I. Absorption of THC and Formation of 11-OH-THC and THCCOOH During and After Smoking Marijuana*Journal of Analytical Toxicology, 1992
- Passive inhalation of cannabis smokeJournal of Pharmacy and Pharmacology, 1984
- Effects of tobacco smoking and oral contraceptive use on theophylline disposition.British Journal of Clinical Pharmacology, 1983